Application 022071
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LAMISIL | TERBINAFINE HYDROCHLORIDE | GRANULE;ORAL | EQ 125MG BASE/PACKET | Yes | No |
| 002 | LAMISIL | TERBINAFINE HYDROCHLORIDE | GRANULE;ORAL | EQ 187.5MG BASE/PACKET | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022071-001 | LAMISIL | TERBINAFINE HYDROCHLORIDE | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | |
| N022071-002 | LAMISIL | TERBINAFINE HYDROCHLORIDE | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022071-001 | LAMISIL | EQ 125MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022071-002 | LAMISIL | EQ 187.5MG BASE/PACKET | GRANULE / ORAL | RLD | 2007-09-28 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| terbinafine hydrochloride | TERBINAFINE HYDROCHLORIDE | REMEDYREPACK INC. | 2886b2ff-815f-4621-bc28-1fea082c1920 | 2026-07-09 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Athlete Foot Cream | TERBINAFINE HYDROCHLORIDE | Beautivity LLC | 3b2c1d7f-32c3-aa3b-e063-6394a90a6267 | 2026-06-29 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Scholl's Wellness Company LLC | 31f59302-eaee-211b-e063-6294a90a08b0 | 2026-04-03 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | American Health Packaging | 4ee1b667-0cf6-46e4-a740-4fc27904d577 | 2026-03-06 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Sun Pharmaceutical Industries, Inc. | 92b31fc4-0f02-4857-b11f-49b9f942ee84 | 2026-02-20 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | REMEDYREPACK INC. | 44c6f6e7-e0c0-450e-83ce-1ed4f3efddec | 2026-02-13 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Northwind Health Company, LLC | ab6f50a5-87ce-0819-e053-2a95a90a22b7 | 2026-01-01 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | A-S Medication Solutions | 5de4c245-7086-453b-b90a-7a1242ec2c0b | 2025-12-18 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT | TERBINAFINE HYDROCHLORIDE | Karo Healthcare Inc. | 21f1bf77-4338-4b75-b513-80a0d98a722a | 2025-12-12 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT | TERBINAFINE HYDROCHLORIDE | Karo Healthcare Inc. | d3e75665-e2d4-47d9-baaa-93817b5fbf00 | 2025-12-12 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Walgreens Athletes Foot | TERBINAFINE HYDROCHLORIDE | Walgreen Company | d706c56f-0123-4a5a-8c85-240cbe6ef7a5 | 2025-11-26 | Warnings | TERBINAFINE HYDROCHLORIDE |
| CVS | TERBINAFINE HYDROCHLORIDE | CVS Pharmacy | 17684ba2-3c2c-4259-84fa-3833f19e5a4d | 2025-11-25 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Golden State Medical Supply, Inc. | b43e4644-024c-4aa6-b403-19152c785802 | 2025-11-25 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT Cream | TERBINAFINE HYDROCHLORIDE | Voyant Beauty Inc. | 9dea4789-bf1c-1577-e053-2a95a90a5381 | 2025-11-18 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Good Neighbor Pharmacy | TERBINAFINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 0a9e890c-1eed-4fde-a484-852a4dd135c2 | 2025-10-17 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 2df111dc-ecac-4161-9e22-38436eb37c1f | 2025-10-17 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 747fdc13-7c3a-4672-b50c-31c51037bda2 | 2025-10-14 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
| Lamisil AT Cream | TERBINAFINE HYDROCHLORIDE | Karo Healthcare Inc. | 1aa5e03a-432b-4154-ab6e-6dbce7a67109 | 2025-10-02 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine Hydrochloride | TERBINAFINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc | 6016e546-6c02-4af0-888c-c0899865c5f0 | 2025-09-30 | Warnings | TERBINAFINE HYDROCHLORIDE |
| Terbinafine | TERBINAFINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | 085e0809-6b7f-447e-976e-8276c29daad6 | 2025-09-30 | Warnings, Adverse reactions | TERBINAFINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 58167 | SUPPL | 2019-04-01 |
| 56373 | SUPPL | 2018-11-08 |
| 46957 | SUPPL | 2017-01-24 |
| 46947 | SUPPL | 2017-01-24 |
| 45230 | SUPPL | 2016-08-23 |
| 38192 | SUPPL | 2013-10-25 |
| 6827 | SUPPL | 2013-10-25 |
| 29202 | SUPPL | 2013-06-18 |
| 38191 | SUPPL | 2013-06-17 |
| 6826 | SUPPL | 2012-04-25 |
| 16894 | SUPPL | 2012-04-23 |
| 6825 | SUPPL | 2011-11-08 |
| 16893 | SUPPL | 2011-04-01 |
| 6824 | SUPPL | 2011-03-31 |
| 6823 | SUPPL | 2010-12-07 |
| 38190 | SUPPL | 2010-12-04 |
| 21926 | ORIG | 2009-03-12 |
| 38189 | ORIG | 2007-10-04 |
| 6822 | ORIG | 2007-10-04 |
| 53414 | ORIG | 1900-01-01 |
| 53413 | ORIG | 1900-01-01 |
| 53412 | ORIG | 1900-01-01 |